52096-71-6

Basic information

• Product Name: 1H-Isoindole-1,3(2H)-dione, 2-[4-[(phenylmethyl)thio]butyl]-
• CAS NO: 52096-71-6
• Molecular Formula: C19H19NO2S
• Molecular Weight: 325.431
• Mol File: 52096-71-6.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 1H-Isoindole-1,3(2H)-dione, 2-[4-[(phenylmethyl)thio]butyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Isoindole-1,3(2H)-dione, 2-[4-[(phenylmethyl)thio]butyl]-(52096-71-6)
• EPA Substance Registry System: 1H-Isoindole-1,3(2H)-dione, 2-[4-[(phenylmethyl)thio]butyl]-(52096-71-6)

Safety Data

• Hazardous Substances Data: 52096-71-6(Hazardous Substances Data)

Upstream product

• 5394-18-3 2-(4-bromobutyl)isoindoline-1,3-dione 
• 100-39-0 benzyl bromide 
• 118312-98-4 2-(4-mercaptobutyl)isoindoline-1,3-dione 
• 1074-82-4 potassium phtalimide 
• 396073-46-4 S-(4-(1,3-dioxoisoindolin-2-yl)butyl) ethanethioate 
• 100-53-8 phenylmethanethiol 

Downstream Products

• 1414791-81-3 (((4-isothiocyanatobutyl)sulfinyl)methyl)benzene 
• 1414792-73-6 benzyl(4-isothiocyanatobutyl)sulfane 
• 1445972-75-7 C₁₂H₁₅NO₂S₂ 
• 98184-56-6 1-(Benzylthio)-3,4-dihydropyrido<2,1-a>isoindol-6(2H)-one 
• 98184-53-3 cis-1-(Benzylthio)-1,3,4,10b-tetrahydro-10b-hydroxypyrido<2,1-a>isoindol-6(2H)-one 

Relevant articles and documents

THIOESTER CATIONIC LIPIDS

Disclosed are cationic lipids which are compounds of Formula (I), (II), (III), (IV), (V), or (VI). Cationic lipids provided herein can be useful for delivery and expression of mRNA and encoded protein, e.g., as a component of liposomal delivery vehicle, a

Synthesis and biological evaluation of sulforaphane derivatives as potential antitumor agents

A series of sulforaphane derivatives were synthesized and evaluated in vitro for their cytotoxicity against five cancer cell lines (HepG2, A549, MCF-7, HCT-116 and SH-SY5Y). The pharmacological results showed that many of the derivatives displayed more potent cytotoxicity than sulforaphane (SFN). Furthermore, SFN and derivative 85 could induce cell cycle arrest at S or G2/M phase and cell apoptosis. SFN and 85 exhibited time- and dose-dependent activation on Nrf2 transcription factor, and 85 acted as a more potent Nrf2 inducer than SFN.

Dimethyl tyrosyl amide sulfides, sulfoxides and sulfones

The present invention relates to new compounds of the formula STR1 and the pharmaceutically acceptable salts thereof and the enantiomers thereof, wherein R1 is H, lower alkyl, alkenyl, aralkyl, or C(O)R2 wherein R2 is lowe